Clinical Trial Update: Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update involving Avastin and Tarceva for locally advanced or metastatic non-squamous non-small cell lung cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED